Safran SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Safran SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3584
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:航空・防衛
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,150見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥48,300見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥72,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Safran SA – Strategy, SWOT and Corporate Finance Report
Summary

Safran SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Safran SA (Safran or ‘the group’) is an international high-technology group with three core businesses: aerospace, defense, and security. The group engages in the production of engines for commercial aircraft, military aircraft, and helicopter and space engines in around 60 contries. Safran also designs, develops, manufactures and markets optronic, avionic and electronic solutions and services, and critical software for civil and defense applications. The group operates worldwide, through offices and facilities in Europe, the Americas, Africa, and Asia-Pacific. It is headquartered in Paris, France.

Scope

- Detailed information on Safran SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Safran SA in the form of a SWOT analysis
- An in-depth view of the business model of Safran SA including a breakdown and examination of key business segments
- Intelligence on Safran SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Safran SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Safran SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Safran SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Safran SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Safran SA: Company Overview 9
Safran SA: Overview and Key Facts 9
Safran SA: Overview 9
Safran SA: Key Facts 9
Safran SA: Key Employees 10
Safran SA: Key Employee Biographies 12
Safran SA: Major Products and Services 19
Safran SA: Company History 21
Safran SA: Management Statement 33
Safran SA: Locations and Subsidiaries 35
Safran SA: Key Competitors 36
Safran SA: Company Analysis 37
Safran SA: Business Description 37
Safran SA: SWOT Analysis 39
Safran SA: SWOT Overview 39
Safran SA: Strengths 39
Safran SA: Weaknesses 40
Safran SA: Opportunities 41
Safran SA: Threats 42
Safran SA: Corporate Financial Deals Activity 44
Safran SA: Financial Deals Overview 44
Safran SA: Targets and Partners 46
Safran SA: Top Deals 2014 – 2018YTD* 47
Safran SA: Advisors 48
Safran SA: Top Legal Advisors 48
Safran SA: Top Financial Advisors 48
Safran SA: Mergers and Acquisitions 49
Safran SA: Capital Raising 50
Safran SA: Partnership 51
Safran SA: Divestments 52
Safran SA: Private Equity and Ownership 53
Safran SA: Recent Developments 54
Safran SA: News and Events Summary 54
Safran SA: Business Expansion 58
Safran SA: Financial Deals 59
Safran SA: Market Developments 59
Safran SA: Regulatory and Legal Events 60
Safran SA: Strategy and Operations 60
Appendix 63
Contact Us 63
Methodology 63
About MarketLine 64

List of Tables
Table 1: Safran SA: Key Facts
Table 2: Safran SA: Key Employees
Table 3: Safran SA: Locations and Subsidiaries
Table 4: Safran SA: Key Competitors
Table 5: Safran SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Safran SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Safran SA: M&A Average Deal Size - Value (US$m)
Table 8: Safran SA: Targets and Partners
Table 9: Safran SA: Top Deals 2014 - 2018YTD*
Table 10: Safran SA: Legal Advisor Ranking by Value (US$m)
Table 11: Safran SA: Financial Advisor Ranking by Value (US$m)
Table 12: Safran SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Safran SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Safran SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Safran SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Safran SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Safran SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Safran SA: Divestments by Geography (2014 - YTD*2018)
Table 19: Safran SA: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Safran SA: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Safran SA: News and Events Summary
Table 22: Safran SA: Business Expansion
Table 23: Safran SA: Financial Deals
Table 24: Safran SA: Market Developments
Table 25: Safran SA: Regulatory and Legal Events
Table 26: Safran SA: Strategy and Operations

List of Figures
Figure 1: Safran SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Safran SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Safran SA: M&A Average Deal Size - Value (US$m)
Figure 4: Safran SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Safran SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Safran SA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Safran SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Safran SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Safran SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Safran SA: Divestments by Geography (2014 - YTD*2018)
Figure 11: Safran SA: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Safran SA: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Safran SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報
    Summary Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technol …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Orbis S.A.:企業の戦略・SWOT・財務情報
    Orbis S.A. - Strategy, SWOT and Corporate Finance Report Summary Orbis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Burmeister & Wain Scandinavian Contractor AS:企業の戦略的SWOT分析
    Burmeister & Wain Scandinavian Contractor AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Caribou Coffee Company Inc:企業の戦略的SWOT分析
    Caribou Coffee Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Delegat’s Group Limited:企業の戦略・SWOT・財務情報
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • 3i Group Plc:企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Guernsey Electricity Ltd:企業の戦略的SWOT分析
    Guernsey Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • F-star Biotechnology Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits …
  • Zebra Technologies Corporation:企業の戦略・SWOT・財務情報
    Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Aldermore Bank Plc:企業の戦略・SWOT・財務分析
    Aldermore Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Aldermore Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RP Management LLC-製薬・医療分野:企業M&A・提携分析
    Summary RP Management LLC (RP Management) is a life sciences financing company which offers biopharmaceutical products. Its products portfolio includes rituxan, atripla, thalomid, myozyme, lexiscan, januvia, onglyza, lyrica, prezista, letairis, rotateq, cubicin, savella, neupogen, and others. The co …
  • French National Institute of Health and Medical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆